爱尔兰Cellix
爱尔兰Cellix VenaFlux  流体细胞分析系统

By operating under continuous blood flow conditions, the Cellix platform simulates the human environment providing researchers with powerful data far beyond that available via the static conditions of the petri dish before advancing to costly animal trials. By using our solution, false leads can be eliminated earlier in the process, increasing the success rate of clinical trials and giving you the competitive edge.

Cellix is an Irish company that has developed a ground breaking microfluidics drug screening tool currently being used by over a third of the top ten pharmaceutical companies worldwide.

Our solution is unique and contains everything a researcher requires to execute continuous flow cell based assays and make informed decisions. The only fully integrated end-to-end Microfluidics system on the market, the Cellix solution includes the platform, biochips and cell analysis software. During the consultation phase, our team will run a demonstration in your lab and ensure your team are fully trained to get the most from the platform within your specialist disease area.

Over a third of the top ten leading pharmaceutical companies are already using Cellix's technology to study drug effects on cell activity for cardiovascular, oncology, respiratory and bacteriology.